PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPsd502
Psd502
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
158 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R522346721
Local anesthesiaD000772———22238
ContraceptionD003267————32—5
Actinic keratosisD055623—L57.03——115
KeratosisD007642——3——115
Acute painD059787—R52———123
LacerationsD022125—————112
CicatrixD002921—L90.51——1—2
Postoperative painD010149—G89.18———112
SyndromeD013577—————112
Show 18 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Premature ejaculationD061686—F52.4222—16
Procedural painD000073818————1—45
Premature birthD047928EFO_0003917O60122—15
AnalgesiaD000698————1—12
AgnosiaD000377EFO_0007136F88——1—12
InfertilityD007246EFO_0000545———1—12
Systemic sclerodermaD012595EFO_0000717M34——1——1
Neoplasm metastasisD009362EFO_0009708———1——1
Raynaud diseaseD011928EFO_1001145I73.0——1——1
Diffuse sclerodermaD045743EFO_0000404———1——1
Show 12 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Wounds and injuriesD014947—T14.8—2——13
NeuralgiaD009437EFO_0009430——1——12
NeoplasmsD009369—C80—1——12
Cognitive dysfunctionD060825—G31.8411——12
CarcinomaD002277—C80.011———2
UlcerD014456MPATH_579——1——12
Leg ulcerD007871———1——12
Spinal cord injuriesD013119EFO_1001919——1———1
Back painD001416—M54—1———1
HyperalgesiaD006930———1———1
Show 10 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———3———47
Skin diseasesD012871—L00-L992————2
Bowen's diseaseD001913—D00-D091————1
Squamous cell carcinomaD002294——1————1
Hidradenitis suppurativaD017497—L73.21————1
HidradenitisD016575——1————1
Mouth diseasesD009059EFO_1001047K131————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.9————22
PruritusD011537—L29————22
Pain perceptionD058748——————22
Muscle spasticityD009128——————11
VulvodyniaD056650—N94.81————11
Vulvar vestibulitisD054515—N94.810————11
MyomaD009214—D21————11
CapsicumD002212——————11
Small fiber neuropathyD000071075——————11
HypesthesiaD006987——————11
Show 52 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use